October 21, 2016
Posted October 24, 2016
Mark Gilmore, owner of Florida compound pharmacy QMedRx, agreed to pay $4.25 million to settle charges that he violated the False Claims Act by billing the government for services that were not reimbursable. Specifically, the government contends that QMedRx submitted to federal healthcare programs compounded prescriptions that were tainted within the meaning of the Anti-Kickback Statute. The government is still pursuing penalties and fines from other participants within QMedRx. DOJ (MDFL)
Tagged in: Anti-Kickback and Stark, FCA Federal,